Drug Shortage Report for APO-CEFADROXIL

Last updated on 2024-03-08 History
Report ID 190008
Drug Identification Number 02240774
Brand name APO-CEFADROXIL
Common or Proper name CEFADROXIL
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CEFADROXIL
Strength(s) 500MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-18
Estimated end date 2024-03-15
Actual end date 2024-03-07
Shortage status Resolved
Updated date 2024-03-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v38 2024-03-08 French Compare
v37 2024-03-08 English Compare
v36 2024-03-01 French Compare
v35 2024-03-01 English Compare
v34 2024-01-26 French Compare
v33 2024-01-26 English Compare
v32 2023-12-22 French Compare
v31 2023-12-22 English Compare
v30 2023-10-20 French Compare
v29 2023-10-20 English Compare
v28 2023-10-06 French Compare
v27 2023-10-06 English Compare
v26 2023-09-15 French Compare
v25 2023-09-15 English Compare
v24 2023-09-07 French Compare
v23 2023-09-07 English Compare
v22 2023-07-27 French Compare
v21 2023-07-27 English Compare
v20 2023-06-29 French Compare
v19 2023-06-29 English Compare

Showing 1 to 20 of 38